JP2017529084A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017529084A5 JP2017529084A5 JP2017515764A JP2017515764A JP2017529084A5 JP 2017529084 A5 JP2017529084 A5 JP 2017529084A5 JP 2017515764 A JP2017515764 A JP 2017515764A JP 2017515764 A JP2017515764 A JP 2017515764A JP 2017529084 A5 JP2017529084 A5 JP 2017529084A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- virus
- coding region
- genomic segment
- vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462053443P | 2014-09-22 | 2014-09-22 | |
| US62/053,443 | 2014-09-22 | ||
| PCT/US2015/051337 WO2016048949A1 (en) | 2014-09-22 | 2015-09-22 | Pichinde virus reverse genetics system and methods of use |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2017529084A JP2017529084A (ja) | 2017-10-05 |
| JP2017529084A5 true JP2017529084A5 (https=) | 2021-05-06 |
| JP6875274B2 JP6875274B2 (ja) | 2021-05-19 |
| JP6875274B6 JP6875274B6 (ja) | 2021-06-30 |
Family
ID=54238628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017515764A Active JP6875274B6 (ja) | 2014-09-22 | 2015-09-22 | ピチンデウイルスのリバースジェネティクス系及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10533159B2 (https=) |
| EP (1) | EP3198008B1 (https=) |
| JP (1) | JP6875274B6 (https=) |
| KR (1) | KR20170057384A (https=) |
| CN (1) | CN107109371A (https=) |
| AU (1) | AU2015321557B2 (https=) |
| BR (1) | BR112017005744B1 (https=) |
| CA (1) | CA2961913A1 (https=) |
| ES (1) | ES2746150T3 (https=) |
| MX (1) | MX391006B (https=) |
| PL (1) | PL3198008T3 (https=) |
| WO (1) | WO2016048949A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107109371A (zh) | 2014-09-22 | 2017-08-29 | 明尼苏达大学评议会 | 皮钦德病毒反向遗传学系统及其使用方法 |
| SI3218504T1 (sl) * | 2014-11-13 | 2020-11-30 | Universite De Geneve | Tri-segmentirani arenavirusi kot vakcinski vektorji |
| AU2016274655B2 (en) | 2015-06-10 | 2021-06-17 | NeoTrail Therapeutics, Inc. | HPV vaccines |
| CA3003557A1 (en) | 2015-11-04 | 2017-05-11 | Hookipa Biotech Ag | Vaccines against hepatitis b virus |
| DK3373959T3 (da) | 2015-11-12 | 2022-09-19 | Hookipa Biotech Gmbh | Arenaviruspartikler som cancervacciner |
| IL262963B2 (en) * | 2016-05-18 | 2025-01-01 | Hookipa Biotech Gmbh | Trisegmented PICHINDE viruses as vaccine vectors |
| US20230310574A1 (en) * | 2020-08-06 | 2023-10-05 | Regents Of The University Of Minnesota | Multivalent vaccines against turkey arthritis reovirus |
| WO2022269362A2 (en) | 2021-06-21 | 2022-12-29 | Vaxxinova International B.V. | Veterinary viral vector |
| WO2024155646A1 (en) * | 2023-01-17 | 2024-07-25 | Regents Of The University Of Minnesota | Multivalent vaccines against tuberculosis |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2170622B1 (es) | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
| ES2424214T3 (es) | 2007-08-27 | 2013-09-30 | Siga Technologies, Inc. | Medicamentos antivirales para el tratamiento de una infección por Arenavirus |
| AP3126A (en) | 2007-12-21 | 2015-02-28 | Government Of The Us Secretary | Recombinant rift valley fever (RVF) viruses and methods of use |
| SI2604695T1 (sl) * | 2007-12-27 | 2023-03-31 | Universitaet Zuerich Prorektorat Forschung | Replikacijsko defektni arenavirusni vektorji |
| EP2478103A4 (en) | 2009-09-16 | 2014-02-19 | Univ Tulane | LASSAVIRUS-like PARTICLES AND METHOD FOR THE PRODUCTION THEREOF |
| GB201007790D0 (en) | 2010-05-10 | 2010-06-23 | Isis Innovation | Compositions |
| JP2013531496A (ja) | 2010-06-06 | 2013-08-08 | モウント シナイ スクール オフ メディシネ | 組換えrnaウイルス及びその使用 |
| CN107109371A (zh) | 2014-09-22 | 2017-08-29 | 明尼苏达大学评议会 | 皮钦德病毒反向遗传学系统及其使用方法 |
-
2015
- 2015-09-22 CN CN201580063072.3A patent/CN107109371A/zh active Pending
- 2015-09-22 EP EP15772173.9A patent/EP3198008B1/en active Active
- 2015-09-22 BR BR112017005744-1A patent/BR112017005744B1/pt active IP Right Grant
- 2015-09-22 PL PL15772173T patent/PL3198008T3/pl unknown
- 2015-09-22 AU AU2015321557A patent/AU2015321557B2/en active Active
- 2015-09-22 CA CA2961913A patent/CA2961913A1/en active Pending
- 2015-09-22 JP JP2017515764A patent/JP6875274B6/ja active Active
- 2015-09-22 US US15/513,045 patent/US10533159B2/en active Active
- 2015-09-22 MX MX2017003694A patent/MX391006B/es unknown
- 2015-09-22 KR KR1020177010589A patent/KR20170057384A/ko not_active Withdrawn
- 2015-09-22 WO PCT/US2015/051337 patent/WO2016048949A1/en not_active Ceased
- 2015-09-22 ES ES15772173T patent/ES2746150T3/es active Active
-
2019
- 2019-12-10 US US16/708,825 patent/US11993789B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6875274B2 (ja) | ピチンデウイルスのリバースジェネティクス系及び使用方法 | |
| JP2017529084A5 (https=) | ||
| US11180737B2 (en) | Generation of infectious influenza viruses from virus-like particles | |
| CN101903043B (zh) | 经过修饰的流感病毒 | |
| CA2918739C (en) | Attenuated influenza vaccines and uses thereof | |
| CN107208071A (zh) | 用于流感病毒的减弱活疫苗 | |
| JP2023532735A (ja) | 組み換えエンテロウイルスおよびその使用 | |
| KR101908905B1 (ko) | 인플루엔자 바이러스의 h9 및 h5의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 백신 | |
| US10323231B2 (en) | Attenuated influenza vaccines and uses thereof | |
| CN101454023B (zh) | 干扰缺损病毒 | |
| KR101582490B1 (ko) | 인플루엔자 바이러스의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 바이러스 백신 | |
| US10272149B2 (en) | Modified bat influenza viruses and their uses | |
| US20230310574A1 (en) | Multivalent vaccines against turkey arthritis reovirus | |
| Amara | Old, Running and Future Vaccines: Where are we | |
| EP3939991A2 (en) | Novel recombinant influenza virus having immune and therapeutic responses to heterologous influenza virus, and genetic vector and therapeutic vaccine comprising same | |
| WO2022269362A2 (en) | Veterinary viral vector |